Qualcomm Life works with Walgreens on connecting retail apps to medical devices
SAN DIEGO — Qualcomm on Monday announced that its subsidiary, Qualcomm Life is collaborating with Walgreens to power device connectivity with Walgreens mobile and web applications and its Balance Rewards for healthy choices program with medical device connectivity and care coordination capabilities.
“Whether transitioning from a hospital to the home or managing a chronic condition such as heart disease or diabetes, Walgreens connectivity solution powered by Qualcomm Life will allow us to help our customers achieve improved health through regular biometric communication with their providers,” said Adam Pellegrini, Walgreens divisional VP of digital health. “Additionally, Qualcomm Life’s platforms help us to reward participating customers for their choice to become more informed and engaged in their health care.”
“As the nation’s largest retail pharmacy with over 8,200 stores nationwide and with 82 million Balance Rewards members, Walgreens penetration and reach exponentially expands the impact our collaboration can have on patient management, and underscores our vision for a world with access to care anytime and anywhere. This collaboration is a powerful demonstration of how our 2net Platform can amplify proven tools and solutions to enhance a patient’s health and experience,” commented Rick Valencia, SVP and general manager, Qualcomm Life.
Within the apps, Qualcomm Life’s 2net Platform will also enable remote patient monitoring, transitional care support and chronic care management through a secure and seamless transmission of biometric data from patients’ connected medical devices.
Walgreens Balance Rewards for healthy choices members earn points for participating in various health-related programs and tracking progress toward a goal. With medical device connectivity powered by Qualcomm Life, Balance Rewards for healthy choices members can sync select mHealth devices directly to their Balance Rewards account, earning points and enabling pharmacists to electronically access biometrics and health status information. Compatible Walgreens devices include a wrist-worn blood pressure cuff, a traditional blood pressure cuff and a blood glucose meter.
The Walgreens applications and Qualcomm-enabled branded devices will be available to consumers in the first half of 2015.
CRN points to study that reinforces the importance of vitamins and minerals for pregnant women
WASHINGTON — The Council for Responsible Nutrition expressed its support in response to a study, “Effect of Maternal Multiple Micronutrient vs Iron–Folic Acid Supplementation on Infant Mortality and Adverse Birth Outcomes in Rural Bangladesh,” published in December in the Journal of the American Medical Association.
“This new, large study reinforces the importance of vitamins and minerals for pregnant women and their babies, demonstrating that supplementing with multiple micronutrients (the scientific term for essential nutrients required in small amounts) may offer positive, immediate and long-term health benefits," stated Duffy MacKay, SVP, scientific and regulatory affairs, CRN. "The clinical trial, which evaluated outcomes for 22,405 babies, found significant reductions in both preterm births and low birth weights of babies born to women supplementing with multiple micronutrients. In addition, supplementing with multiple micronutrients resulted in a non-statistically significant reduction in stillbirths."
This study demonstrates how supplementation can be impactful on a global level, MacKay added. "There are many under-nourished populations around the world and we commend the researchers for investigating nutritional interventions in a population with a clear need — and we encourage research like this to continue. At the same time, it’s important that we not lose sight of U.S. government data that shows there are serious nutrient shortfalls in our own backyard. Taking a multivitamin is valuable for all women of childbearing age, not only in malnourished populations across the globe, but certainly also for Americans."
CHPA commends administration for signing DASCA into law
WASHINGTON — The Consumer Healthcare Products Association thanked President Obama for signing the Designer Anabolic Steroid Control Act into law last month. DASCA will update the list of anabolic steroids on the controlled substances list and grant the Drug Enforcement Administration authority to temporarily schedule substances if they are suspected anabolic steroids or steroid analogues.
“CHPA thanks the president for signing DASCA into law, as we believe it will help prevent the sale of falsely labeled steroids, which are often illegally marketed as dietary supplements by rogue manufacturers," stated Scott Melville, CHPA president and CEO. "Products containing illegal steroids are not supplements; they are misbranded drugs and a threat to public health."
“Our association has long supported the Food and Drug Administration’s efforts to crack down on the criminals who sell products that are spiked with illegal substances such as steroids or undeclared drugs."
Loading Post Please Wait...